Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 26.60
+0.10 (0.38%)
Mar 23, 2026, 12:10 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 1.11 billion as of March 23, 2026. Its market cap has decreased by -1.21% in one year.
Market Cap
1.11B
Enterprise Value
1.10B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
26.60
Market Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 1.11B, an increase of 194.42%. That is a compound annual growth rate of 13.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.11B | -15.74% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Oncopeptides AB | 1.31B |
| Medivir AB | 1.16B |
| Genovis AB (publ.) | 1.07B |
| Cantargia AB | 959.64M |